NCT01572324
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,038 public trials
1,176 recruiting studies
Adenocarcinoma trial results
NCT00003126
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
- Summit Medical Center Oakland, California, United States
NCT03007212
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
Not specified
NCT00637481
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Breast Cancer, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02893085
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Chu Reims France, Reims
NCT02990351
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified
NCT01767597
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +21 more
- Locations
-
- Centre de Santé au Maire-Volta Paris, France
- Centre d'examen de santé de la CPAM, antenne rue du Maroc Paris, France
- Consultation Policlinique de l'hôpital Saint-Antoine Paris, France
- Consultation Voyage de l'hôpital Saint-Antoine Paris, France
NCT01790633
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Adenocarcinoma, +33 more
- Locations
-
- Consultation d'Accueil, de Soins et d'Orientation (CASO) de Médecins du Monde (MDM) Paris, France
Completed
Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT
NCT02985034
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Completed
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
NCT00006010
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- CCOP - Atlanta Regional Atlanta, Georgia, United States
- MBCCOP - Hawaii Honolulu, Hawaii, United States